Skip to main content
. 2010 Oct 8;5(10):e13223. doi: 10.1371/journal.pone.0013223

Table 2. CSF metabolite profiles in ALS and control subjects measured by 1H NMR spectroscopy.

Metabolites (µmol/L) ALS (n = 50) Non ALS (n = 44) p
AHBT 61 (0–137) 59 (0–177) 0.17
Ethanol 24 (0–170) 24 (0–460) 0.29
Alanine 56 (6–596) 61 (0–214) 0.74
Acetate 53 (9–389) 104 (2–366) 0.0002
BHBT 17 (4–85) 27 (0–134) 0.97
Lactate 2076 (444–3892) 2020 (94–5322) 0.81
Acetoacetate 9 (0–29) 8 (0–29) 0.89
Acetone 11 (0–59) 5 (0–23) 0.015
Glutamine 716 (139–1272) 785 (35–1296) 0.24
Pyruvate 68 (3–128) 17 (0–201) 0.002
Citrate 283 (22–49) 285 (12–754) 0.51
Creatine/creatinine 155 (25–316) 160 (9–450) 0.65
Glucose 3240 (560–7166) 3174 (150–8928) 0.98
Fructose 428 (0–1224) 419 (0–967) 0.82
Ascorbate 25 (0–152) 0 (0–165) 0.003
Tyrosine 12 (0–48) 8 (0–117) 0.35
Formate 28 (3–91) 30 (1–187) 0.35

Data are expressed in median and range. P value inferior to threshold after correction for multiple test (p = 0.003) are shown in bold.

AHBT: Alphahydroxybutyrate.

BHBT: Betahydroxybutyrate.